Cargando…
Benzimidazole scaffolds as promising antiproliferative agents: a review
Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety foun...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661752/ https://www.ncbi.nlm.nih.gov/pubmed/31384813 http://dx.doi.org/10.1186/s13065-019-0579-6 |
_version_ | 1783439517693247488 |
---|---|
author | Tahlan, Sumit Kumar, Sanjiv Kakkar, Saloni Narasimhan, Balasubramanian |
author_facet | Tahlan, Sumit Kumar, Sanjiv Kakkar, Saloni Narasimhan, Balasubramanian |
author_sort | Tahlan, Sumit |
collection | PubMed |
description | Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety found in extensive number of natural and biological active molecules. Benzimidazole derivatives might be considered as auxiliary isosters of nucleotides having attached heterocyclic cores in their structures, cooperate effortlessly with biopolymers and have potential action for chemotherapeutic applications. Benzimidazole and its derivatives displayed a wide range of biological activity because of its structural similarity with the naturally occurring nucleotides. Benzimidazole has established huge alertness in current time and is extremely significant heterocyclic pharmacophore in recent drug innovation and medicinal chemistry. The present review summarizes the chemistry of various substituted benzimidazole derivatives with their antiproliferative significance towards the various cancer cell lines such as HCT116, MCF7, HeLa, HepG2, A549 and A431. [Image: see text] |
format | Online Article Text |
id | pubmed-6661752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-66617522019-08-05 Benzimidazole scaffolds as promising antiproliferative agents: a review Tahlan, Sumit Kumar, Sanjiv Kakkar, Saloni Narasimhan, Balasubramanian BMC Chem Review Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety found in extensive number of natural and biological active molecules. Benzimidazole derivatives might be considered as auxiliary isosters of nucleotides having attached heterocyclic cores in their structures, cooperate effortlessly with biopolymers and have potential action for chemotherapeutic applications. Benzimidazole and its derivatives displayed a wide range of biological activity because of its structural similarity with the naturally occurring nucleotides. Benzimidazole has established huge alertness in current time and is extremely significant heterocyclic pharmacophore in recent drug innovation and medicinal chemistry. The present review summarizes the chemistry of various substituted benzimidazole derivatives with their antiproliferative significance towards the various cancer cell lines such as HCT116, MCF7, HeLa, HepG2, A549 and A431. [Image: see text] Springer International Publishing 2019-05-15 /pmc/articles/PMC6661752/ /pubmed/31384813 http://dx.doi.org/10.1186/s13065-019-0579-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Tahlan, Sumit Kumar, Sanjiv Kakkar, Saloni Narasimhan, Balasubramanian Benzimidazole scaffolds as promising antiproliferative agents: a review |
title | Benzimidazole scaffolds as promising antiproliferative agents: a review |
title_full | Benzimidazole scaffolds as promising antiproliferative agents: a review |
title_fullStr | Benzimidazole scaffolds as promising antiproliferative agents: a review |
title_full_unstemmed | Benzimidazole scaffolds as promising antiproliferative agents: a review |
title_short | Benzimidazole scaffolds as promising antiproliferative agents: a review |
title_sort | benzimidazole scaffolds as promising antiproliferative agents: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661752/ https://www.ncbi.nlm.nih.gov/pubmed/31384813 http://dx.doi.org/10.1186/s13065-019-0579-6 |
work_keys_str_mv | AT tahlansumit benzimidazolescaffoldsaspromisingantiproliferativeagentsareview AT kumarsanjiv benzimidazolescaffoldsaspromisingantiproliferativeagentsareview AT kakkarsaloni benzimidazolescaffoldsaspromisingantiproliferativeagentsareview AT narasimhanbalasubramanian benzimidazolescaffoldsaspromisingantiproliferativeagentsareview |